PLoS ONE (Jan 2018)

Vitamin D and metabolic disturbances in polycystic ovary syndrome (PCOS): A cross-sectional study.

  • Y H M Krul-Poel,
  • P P Koenders,
  • R P Steegers-Theunissen,
  • E Ten Boekel,
  • M M Ter Wee,
  • Y Louwers,
  • P Lips,
  • J S E Laven,
  • S Simsek

DOI
https://doi.org/10.1371/journal.pone.0204748
Journal volume & issue
Vol. 13, no. 12
p. e0204748

Abstract

Read online

ObjectiveTo compare vitamin D status in women with PCOS versus fertile women and subsequently evaluate the association between vitamin D status and metabolic disturbances in PCOS women.MethodsWe conducted a cross-sectional comparison study of 639 women with PCOS and 449 fertile women. Serum 25-hydroxyvitamin D (25(OH)D) was stratified into a severe deficient ( 75 nmol/l) status. The main outcome measures were the difference in vitamin D status between PCOS and fertile women, and the association between serum 25(OH)D and metabolic disturbances in PCOS women only.ResultsSerum 25(OH)D was significantly lower in PCOS women compared to fertile controls (mean 25(OH)D of 49.0 nmol/l versus 64.5 nmol/l). An adjusted significant difference was seen between serum 25(OH)D and homeostasis model assessment (HOMA-IR) (β = 0.76; 95% CI: 0.63-0.91; p ConclusionsThis study demonstrates that women with PCOS have a significantly lower serum 25(OH)D compared to fertile controls. A compromised vitamin D status in PCOS women is associated with a higher HOMA-IR and an unfavourable lipid profile. Large randomized controlled trials are necessary to explore the causality of this linkage.